PL1694697T3 - Zlokalizowane na powierzchni polipeptydy campylobacter jejuni - Google Patents
Zlokalizowane na powierzchni polipeptydy campylobacter jejuniInfo
- Publication number
- PL1694697T3 PL1694697T3 PL04797464T PL04797464T PL1694697T3 PL 1694697 T3 PL1694697 T3 PL 1694697T3 PL 04797464 T PL04797464 T PL 04797464T PL 04797464 T PL04797464 T PL 04797464T PL 1694697 T3 PL1694697 T3 PL 1694697T3
- Authority
- PL
- Poland
- Prior art keywords
- campylobacter
- polypeptides
- campylobacter jejuni
- located polypeptides
- relates
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 241000589875 Campylobacter jejuni Species 0.000 title abstract 2
- 241000589876 Campylobacter Species 0.000 abstract 2
- 238000002255 vaccination Methods 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301726 | 2003-11-21 | ||
| US52461703P | 2003-11-25 | 2003-11-25 | |
| PCT/DK2004/000803 WO2005049641A2 (en) | 2003-11-21 | 2004-11-19 | Surface-located campylobacter jejuni polypeptides |
| EP04797464A EP1694697B1 (en) | 2003-11-21 | 2004-11-19 | Surface-located campylobacter jejuni polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1694697T3 true PL1694697T3 (pl) | 2011-05-31 |
Family
ID=43426113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04797464T PL1694697T3 (pl) | 2003-11-21 | 2004-11-19 | Zlokalizowane na powierzchni polipeptydy campylobacter jejuni |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070178110A1 (pl) |
| EP (1) | EP1694697B1 (pl) |
| JP (1) | JP2008501625A (pl) |
| KR (1) | KR20060129229A (pl) |
| CN (1) | CN1906210A (pl) |
| AT (1) | ATE493431T1 (pl) |
| AU (1) | AU2004291213B2 (pl) |
| CA (1) | CA2546873A1 (pl) |
| DE (1) | DE602004030824D1 (pl) |
| DK (1) | DK1694697T3 (pl) |
| ES (1) | ES2358804T3 (pl) |
| NO (1) | NO20062916L (pl) |
| PL (1) | PL1694697T3 (pl) |
| WO (1) | WO2005049641A2 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1765861B1 (en) * | 2004-06-18 | 2012-02-15 | Enkam Pharmaceuticals A/S | Fgfr binding peptides |
| EA013016B1 (ru) * | 2005-03-31 | 2010-02-26 | Лейден Юниверсити Медикал Сентер | Способы и средства диагностики, профилактики и лечения инфекций mycobacterium и заболевания туберкулезом |
| US9047864B2 (en) | 2009-07-16 | 2015-06-02 | Washington State University | Antigen compositions and methods of inhibiting Campylobacter jejuni bacterial infection and uses of the antigen compositions |
| CA2800830C (en) | 2010-06-09 | 2020-09-08 | The Board Of Trustees Of The University Of Arkansas | Vaccine and methods to reduce campylobacter infection |
| CN104159601B (zh) | 2012-02-01 | 2017-05-24 | 代表亚利桑那大学的亚利桑那董事会 | 弯曲杆菌属免疫原性组合物及其用途 |
| US10248758B2 (en) * | 2013-02-07 | 2019-04-02 | University Of Washington Through Its Center For Commercialization | Self-assembling protein nanostructures |
| US10376571B2 (en) | 2013-03-15 | 2019-08-13 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to enteric pathogens |
| KR20190015712A (ko) | 2016-05-03 | 2019-02-14 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법 |
| CN110520153B (zh) * | 2017-01-27 | 2024-04-02 | 佛罗里达大学研究基金公司 | 在禽类中控制肠道沙门氏菌和减少弯曲杆菌的食品安全疫苗 |
| US12297258B2 (en) * | 2018-07-17 | 2025-05-13 | Humabs Biomed Sa | Antibodies against Campylobacter species |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200344A (en) * | 1990-11-13 | 1993-04-06 | Blaser Martin J | Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens |
| CA2286306A1 (en) * | 1997-04-01 | 1998-10-08 | Human Genome Sciences, Inc. | Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome |
| AU3458299A (en) * | 1998-03-31 | 1999-10-18 | United States Of America, As Represented By The Secretary Of Agriculture, The | Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| JP2000351735A (ja) * | 1999-04-09 | 2000-12-19 | Akzo Nobel Nv | カンピロバクターワクチン |
| CA2296869A1 (en) * | 2000-01-24 | 2001-07-24 | Angela Joe | A surface-exposed lipoprotein to campylobacter jejuni involved in adherence to hep-2 cells |
| AU2002306849A1 (en) * | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
-
2004
- 2004-11-19 ES ES04797464T patent/ES2358804T3/es not_active Expired - Lifetime
- 2004-11-19 AT AT04797464T patent/ATE493431T1/de not_active IP Right Cessation
- 2004-11-19 EP EP04797464A patent/EP1694697B1/en not_active Expired - Lifetime
- 2004-11-19 CA CA002546873A patent/CA2546873A1/en not_active Abandoned
- 2004-11-19 KR KR1020067012402A patent/KR20060129229A/ko not_active Ceased
- 2004-11-19 CN CNA2004800397129A patent/CN1906210A/zh active Pending
- 2004-11-19 US US10/595,909 patent/US20070178110A1/en not_active Abandoned
- 2004-11-19 DK DK04797464.7T patent/DK1694697T3/da active
- 2004-11-19 WO PCT/DK2004/000803 patent/WO2005049641A2/en not_active Ceased
- 2004-11-19 JP JP2006540171A patent/JP2008501625A/ja active Pending
- 2004-11-19 DE DE602004030824T patent/DE602004030824D1/de not_active Expired - Lifetime
- 2004-11-19 PL PL04797464T patent/PL1694697T3/pl unknown
- 2004-11-19 AU AU2004291213A patent/AU2004291213B2/en not_active Expired - Fee Related
-
2006
- 2006-06-21 NO NO20062916A patent/NO20062916L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1097854A1 (en) | 2007-07-06 |
| DK1694697T3 (da) | 2011-04-18 |
| EP1694697A2 (en) | 2006-08-30 |
| ES2358804T3 (es) | 2011-05-13 |
| AU2004291213A1 (en) | 2005-06-02 |
| US20070178110A1 (en) | 2007-08-02 |
| CN1906210A (zh) | 2007-01-31 |
| KR20060129229A (ko) | 2006-12-15 |
| AU2004291213B2 (en) | 2011-09-08 |
| EP1694697B1 (en) | 2010-12-29 |
| WO2005049641A2 (en) | 2005-06-02 |
| JP2008501625A (ja) | 2008-01-24 |
| ATE493431T1 (de) | 2011-01-15 |
| WO2005049641A3 (en) | 2005-10-20 |
| NO20062916L (no) | 2006-08-21 |
| DE602004030824D1 (de) | 2011-02-10 |
| CA2546873A1 (en) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02000192A (es) | Composiciones y metodos para la terapia y diagnostico de cancer de pulmon. | |
| DE60126592D1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
| NZ593289A (en) | Anti-neuropilin-1 antibodies for treating angiogenesis | |
| WO2001040269A3 (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
| WO2001096388A8 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| WO2001096390A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| WO2001034802A3 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| WO2000060076A3 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
| WO2001025272A3 (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
| DK1576967T3 (da) | Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse | |
| TW200728465A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| ATE450547T1 (de) | Eml4-alk-fusionsgen | |
| AU2003253125A8 (en) | Cell penetrating peptides | |
| WO2001079286A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| WO2005012350A3 (en) | Epha2 t-cell epitope agonists and uses therefor | |
| PL343245A1 (en) | Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses | |
| WO2001073027A3 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
| WO2005049641A3 (en) | Surface-located campylobacter jejuni polypeptides | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
| WO2001018046A3 (en) | Ovarian tumor sequences and methods of use therefor | |
| EP1887082A3 (en) | TADG-15: An extracellular serine protease overexpressed in carcinomas | |
| WO2000078960A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| WO2001057207A3 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| WO2007134274A3 (en) | Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy | |
| WO2002062203A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer |